RNAZ TRANSCODE THERAPEUTICS INC Management Changes 8-K Filing 2024 - Amendment to Voting Results Transcode Therapeutics, Inc. filed an amendment to correct a mistake in the voting results of their 2024 Annual Meeting of Shareholders, where all matters submitted to a vote were approved except for the Reverse Stock Split Proposal.Get access to all SEC 8-K filings of the TRANSCODE THERAPEUTICS INC